Treatment of chronic headaches
US12397010B2 · kind B2 · utility
0Cited by
8References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 14, 2020 |
| Grant date | Aug 26, 2025 |
| Priority date | — |
| Expiry date | May 3, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D473/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are methods and compositions for the treatment and prevention of migraine, migraine-like headaches such as post-traumatic headache, and other related headaches by administering to a subject in need thereof a selective agonist for the human adenosine A3 receptor (A3AR) subtype.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.